AGP Picks
View all

Wise Up PR Named As Agency Of Record For TruTechnologies

The logos of Wise Up PR and TruTechnologies to announce PR Agency Of Record News

Wise Up PR appointed PR Agency Of Record by Lite Coms

Wise Up PR appointed to lead media relations, thought leadership and strategic communications for clinical trial technology innovator TruTechnologies.

For Wise Up PR, this is also an important moment as we continue to grow our agency specialism across health tech, life sciences and the wider B2B healthcare market.”
— David Claxton, Founder, Wise Up PR

BOSTON, MA, UNITED STATES, October 21, 2026 /EINPresswire.com/ -- Wise Up PR today announces that TruTechnologies (Tru) has appointed the agency as its PR Agency Of Record (AOR).

Founded in 2018, Tru has pioneered the industry’s first Live Clinical Trial Execution platform, bringing visibility and control to the work happening at clinical trial sites. Dynamic, protocol-guided workflows help site teams perform required activities correctly the first time, while Live Data Capture™ gives sponsors instant visibility into trial execution so they can identify and address issues before they escalate. Deployed across more than 3,300 sites in 60 countries, the company has demonstrated up to a 97% reduction in source data errors and a verified three-month reduction in time to market, helping therapies reach patients sooner.

The appointment also comes at a time of significant change within the biotech and pharmaceutical industries, with recent federal initiatives, including the FDA’s real-time clinical trials pilot program and HHS’s Operation TrialBlazer, reflecting growing efforts to modernize clinical development and how clinical trials are conducted. There’s also mounting pressure on the United States to stay competitive in drug development, with clinical trial processes in countries like Australia and China offering speedier pathways to get drugs to market and patients.

Wise Up PR will drive media relations, thought leadership, awards and event support for Tru, with the objective of cementing the company's industry-leading role in clinical trial technology innovation. Key pillars of activity include executive profiling to strengthen Tru's spokespeople as authoritative industry voices and enhanced brand recognition to drive continued business growth and expansion. The work is already underway, with the team at Wise Up PR managing media relations for Tru's recently announced rebrand.

The selection of Wise Up PR follows a competitive review process, with Tru citing the agency's senior-led team model and its track record in bolstering corporate reputations as decisive factors in the appointment.

Supporting Tru marks a further expansion of Wise Up PR's health tech portfolio, broadening the agency's media relations expertise across life sciences and the overall B2B health sector. The account win builds on the agency's established experience of representing companies that operate within complex and highly regulated industries as well as its continued expansion into specialist B2B technology industries.

Sarah Sinning, Public Relations Manager, TruTechnologies, said: “There's increased industry and regulatory urgency to tangibly address clinical trial modernization and we believe that Tru needs to be at the forefront of that conversation, making earned media a key channel for our brand. As we continue to grow quickly, Wise Up PR stood out during the review process as a long-term partner due to its senior team and strategic approach to our communications goals."

David Claxton, Founder of Wise Up PR, said of the appointment: “Tru isn't just talking about modernizing clinical trials; it's already doing it and is trusted by leading sponsors across the world to provide live data, made available the moment it's captured at the point of care. We're excited to work together and see a clear PR opportunity to enhance Tru's position and recognition across the industry. For Wise Up PR, this is also an important moment as we continue to grow our agency specialism across health tech, life sciences and the wider B2B healthcare market."

About TruTechnologies
TruTechnologies is the industry’s first Live Clinical Trial Execution platform, redefining the speed and reliability of clinical trials. Tru combines dynamic, protocol-guided workflows, Live Data Capture™, and instant sponsor visibility to help teams prevent deviations and surface risks earlier, so therapies reach patients sooner. Trusted by leading pharma companies and deployed across 3,300+ sites in 60 countries, Tru delivers real-world partnership and proven results. Because when clinical trials succeed, patients win. To learn more, visit TruTechnologies.ai.

About Wise Up PR
Wise Up PR is a boutique B2B public relations agency founded in 2021. Founder-owned and operated by PR veteran, David Claxton, it delivers media relations, corporate communications, content creation and social media support to a varied client portfolio, crafting campaigns that reach and resonate with media, investors and analysts. Based in Boston with global reach, the agency specializes in serving industries including deep tech, defense, space, robotics, autonomous systems, automotive and mobility, sensors, geospatial, fintech, crypto and digital assets, B2B technology, health tech and energy. To learn more about Wise Up PR, please visit www.wiseup.pr.

David Claxton
Wise Up PR
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

MarCom America

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.